Supporting Evidence

1535 bookmarks
Newest
Petition: Open a Public Inquiry into Covid-19 Vaccine Safety
Petition: Open a Public Inquiry into Covid-19 Vaccine Safety
There has been a significant increase in heart attacks and related health issues since the rollout of the Covid-19 vaccines began in 2021. This needs immediate and full scientific investigation to establish if there is any possible link with the Covid-19 vaccination rollout.
·petition.parliament.uk·
Petition: Open a Public Inquiry into Covid-19 Vaccine Safety
MHRA confirms the UK has recorded 5 times more Deaths in 12 months due to Covid-19 Vaccination than it has Deaths due to every other Vaccine combined in 21 years
MHRA confirms the UK has recorded 5 times more Deaths in 12 months due to Covid-19 Vaccination than it has Deaths due to every other Vaccine combined in 21 years
The UK Medicine Regulator has confirmed that over a period of twelve months the Covid-19 Vaccines have caused five times more deaths than the total number of deaths due to all other available vacci…
·dailyexpose.uk·
MHRA confirms the UK has recorded 5 times more Deaths in 12 months due to Covid-19 Vaccination than it has Deaths due to every other Vaccine combined in 21 years
Covid-19: How independent were the US and British vaccine advisory committees?
Covid-19: How independent were the US and British vaccine advisory committees?
Experts who sit on national vaccine advisory panels are asked to disclose any industry ties and other conflicts of interest. But Paul D Thacker finds that disclosure standards differ widely, often leaving the public in the dark In the wake of lightning fast authorisations of covid-19 vaccines in the UK and the US, public health officials have worked hard to maintain confidence in these new products. British and American officials have emphasised the independence of the experts who authorise vaccines and those who issue advice on them. But an investigation by The BMJ has found that some of these experts have significant industry ties that government agencies do not always disclose. We looked at experts sitting on the covid-19 authorisation committees at the US Food and Drug Administration (FDA), as well as those on the UK’s Joint Committee on Vaccination and Immunisation (JCVI), which advises the government on vaccines. It was not possible to repeat the exercise with the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA), which licenses medicines and gave temporary authorisation for covid-19 vaccines, because the MHRA and its adviser, the Commission on Human Medicines, make almost none of their meetings or documents public.1 Both the FDA and the UK government require panellists to disclose conflicts only from the previous 12 months, which can miss significant financial payments that occurred in recent years. We also found examples where panellists disclosed to committees their grants, patents, and other industry relationships in their publications, but it seems that the committees did not find these matters worth making public, and they remained undisclosed until now. Most experts on the FDA and JCVI committees registered no conflicts of interest. From the JCVI’s December meeting on 22 December 2020, the minutes report that 18 of 19 members had “no registered conflicts …
·bmj.com·
Covid-19: How independent were the US and British vaccine advisory committees?
The drugs industry and its watchdog: a relationship too close for comfort?
The drugs industry and its watchdog: a relationship too close for comfort?
It would appear to be a happy and satisfying relationship. "Our priorities are aligned," says one document. There have been "notable successes" says another, citing "another example" of where the two sides "cooperated well". In business partners, this would seem to indicate a harmony of views. The documents obtained by the Guardian, however, relate to meetings between the drug industry and the watchdog body set up by government to police it.
·theguardian.com·
The drugs industry and its watchdog: a relationship too close for comfort?
£20m ‘secret payments’ to plug drugs by Astrazeneca and Shire
£20m ‘secret payments’ to plug drugs by Astrazeneca and Shire
Two of the UK stock market’s biggest pharmaceutical companies have made millions of pounds in “secret” payments to healthcare professionals and organisations, an investigation by The Times has found.At least €22.3 million (£19.6 million) was made in anonymous payments across Europe, including €17.9
·thetimes.co.uk·
£20m ‘secret payments’ to plug drugs by Astrazeneca and Shire
Dollars for Docs
Dollars for Docs
ProPublica has compiled the disclosed payments from pharma companies to doctors and other health care providers. Search for your doctor in our interactive database.
·projects.propublica.org·
Dollars for Docs